Wang Meng, Tian Tian, Ma Xiaobin, Zhu Wenge, Guo Yan, Duan Zhao, Fan Jiangbo, Lin Shuai, Liu Kang, Zheng Yi, Sheng Qianwen, Dai Zhi-Jun, Peng Huixia
Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Department of Biochemistry and Molecular Medicine, The George Washington University Medical School, Washington, DC, USA.
Oncotarget. 2017 Oct 6;8(53):91654-91661. doi: 10.18632/oncotarget.21560. eCollection 2017 Oct 31.
Caveolin-1() was demonstrated to be a tumor suppressor gene and be implicated in the development of breast cancer (BC). Numerous potentially functional polymorphisms in have been identified, but their effects on BC were not clear. This case-control study aims to evaluate the relationship between polymorphisms and BC risk. 560 BC patients and 583 healthy controls were enrolled in the present study, all from Chinese Han population. We detected 3 single nucleotide polymorphisms (rs3807987, rs1997623, and rs7804372) in using the Sequenom MassARRAY method. The association between genotypes and BC risk was assessed in six genetic models by calculating the odds ratio (OR) and 95% confidence intervals (95% CIs) with χ-test. The rs3807987 polymorphism was observed to increase the risk of BC And the A allele of rs3807987 relates to a larger tumor size (≥2cm) and lower incidence of PR-positive BC while the AA genotype of rs7804372 associates with a higher ER and Her-2 positive rate among BC patients. In addition, AGT haplotype was linked to a decreased risk of BC (OR =0.64, 95%CI=0.44-0.93), whereas CAT haplotype was related to an increased BC risk (OR =1.74, 95%CI=1.04-2.92). Our study suggests that rs3807987 can increase the BC risk among Chinese Han women. And the rs3807987 and rs7804372 in may serve as predictors for prognosis of BC.
小窝蛋白-1(Caveolin-1)被证明是一种肿瘤抑制基因,并与乳腺癌(BC)的发生发展有关。已在其中鉴定出许多潜在的功能性多态性,但它们对BC的影响尚不清楚。本病例对照研究旨在评估Caveolin-1多态性与BC风险之间的关系。本研究纳入了560例BC患者和583例健康对照,均来自中国汉族人群。我们使用Sequenom MassARRAY方法检测了Caveolin-1中的3个单核苷酸多态性(rs3807987、rs1997623和rs七804372)。通过计算比值比(OR)和95%置信区间(95%CI)并进行χ检验,在六种遗传模型中评估基因型与BC风险之间的关联。观察到Caveolin-1的rs3807987多态性会增加BC风险,rs3807987的A等位基因与更大的肿瘤大小(≥2cm)相关,且PR阳性BC的发生率较低,而rs7804372的AA基因型与BC患者中较高的ER和Her-2阳性率相关。此外,AGT单倍型与BC风险降低相关(OR = 0.64,95%CI = 0.44 - 0.93),而CAT单倍型与BC风险增加相关(OR = 1.74,95%CI = 1.04 - 2.92)。我们的研究表明,Caveolin-1的rs3807987可增加中国汉族女性的BC风险。并且Caveolin-1中的rs3807987和rs7804372可能作为BC预后的预测指标。